Works matching IS 21534888 AND DT 2019 AND VI 10 AND IP 6
Results: 27
Genetic Profiling and Personalized Medicine in Myelodysplastic Syndromes.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 29
- By:
- Publication type:
- Article
What Is the Role of Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukemia?
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 28
- By:
- Publication type:
- Article
Biosimilars Are Key Components of Oncology Today: Brush Up on the Basics.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 27
- By:
- Publication type:
- Article
Five-Year Survival Rates with BRAF-MEK Inhibitors in Metastatic Melanoma with BRAF Mutation.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 24
- Publication type:
- Article
Selinexor-Dexamethasone Combination Improves Outcomes in Patients with Multiple Myeloma Refractory to 3 Drug Classes.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 24
- Publication type:
- Article
Value-Based Care Management Medicare Program Changes for 2020 and Beyond.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 23
- By:
- Publication type:
- Article
The Future of Cancer Care: Change Is the Only Certainty.
- Published in:
- 2019
- Publication type:
- Proceeding
Payers' Perspectives on Value in Cancer Care.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 22
- Publication type:
- Article
Barriers to Value-Based Contracting in Oncology.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 21
- Publication type:
- Article
Ensuring Patient Access to Cancer Care Must Be a Priority.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 20
- Publication type:
- Article
Zejula Receives FDA Approval for HRD-Positive Advanced Ovarian Cancer.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 18
- Publication type:
- Article
Pemigatinib Effective in Patients with Cholangiocarcinoma and FGFR2 Fusion or Rearrangement.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 18
- By:
- Publication type:
- Article
Practice-Changing Results: Ivosidenib First Targeted Therapy to Show Benefits in Patients with Cholangiocarcinoma and IDH1 Mutation.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 16
- By:
- Publication type:
- Article
Medical Cannabis in Patients with Advanced Cancer: Many Challenges Remain.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 15
- Publication type:
- Article
Psychosocial Issues in Patients with Cancer: It's Time for Real-World Interventions.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 14
- By:
- Publication type:
- Article
Nivolumab plus Ipilimumab Combination Improves Survival in Patients with Metastatic NSCLC.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 13
- By:
- Publication type:
- Article
FDA Approves Calquence for Adults with CLL or SLL.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 12
- Publication type:
- Article
Osimertinib Superior TKI as First-Line Treatment of Advanced NSCLC with EGFR Mutation.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 12
- By:
- Publication type:
- Article
Tecentriq Approved with Chemotherapy for First-Line Treatment of Metastatic NSCLC without EGFR or ALK Mutation.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 11
- Publication type:
- Article
Ziextenzo Third Biosimilar to Neulasta Approved for Febrile Neutropenia.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 11
- Publication type:
- Article
Brukinsa Receives Accelerated FDA Approval for Mantle-Cell Lymphoma.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 10
- Publication type:
- Article
Targeted Therapy with Olaparib Beneficial in Metastatic Prostate Cancer with Gene Mutations.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 10
- By:
- Publication type:
- Article
Ceritinib Effective in Treating Brain Metastases in NSCLC.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 9
- By:
- Publication type:
- Article
Selecting Treatment for Relapsed/Refractory Multiple Myeloma in the Era of Multiple Choices.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 1
- By:
- Publication type:
- Article
Paradigm Shift: PARP Inhibitors Should Be Offered to All Patients with Ovarian Cancer.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 1
- By:
- Publication type:
- Article
Steroids plus Exercise Reduce Fatigue in Patients with Advanced Cancer.
- Published in:
- Value-Based Cancer Care, 2019, v. 10, n. 6, p. 1
- By:
- Publication type:
- Article
Real-World Applications of Value-Based Care in Oncology.
- Published in:
- 2019
- Publication type:
- Proceeding